Filter Results:
(356)
Show Results For
- All HBS Web
(356)
- People (2)
- News (141)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (72)
Show Results For
- All HBS Web
(356)
- People (2)
- News (141)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (72)
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
Jeffrey Wiesen, an attorney specializing in biotechnology, the standard routine was "more a work-for-hire model than a collaboration model, although we always called it collaboration." In a nutshell, it worked like this, Wiesen said. "A View Details
- 13 Feb 2023
- News
Alumnus Gift Will Nurture Basic, Therapeutic Science
Swiss biotech executive, entrepreneur, and philanthropist Ernesto Bertarelli (MBA 1993) has pledged $75 million to advance basic scientific discovery, therapeutic science, and a culture of entrepreneurship at Harvard Medical School. The... View Details
- Web
Contemporary Corporate Archives | Baker Library
hedge funds, etc., responsible for the development of modern global finance infrastructure; papers of significant leaders and thinkers in the financial field; and biotechnology industry records, especially those that illustrate Boston-area View Details
- 03 Oct 2019
- News
Clubs Convene to Focus on Health Care
as a retiree, investors, and entrepreneurs; alumni working in a range of health care sectors, from biotech and research to pharma and the provider side of it as well. It was a chance to get connected. There was no agenda and no speaker.... View Details
- 24 Aug 2020
- Blog Post
My Journey to Joining the first MS/MBA Biotechnology: Life Sciences Cohort
explore the biopharma world, so I joined L.E.K. Consulting after graduation and made my way to their Life Sciences practice. At L.E.K., I learned a tremendous amount about various pharma and biotech companies and their therapies. I worked... View Details
- 01 Dec 2013
- News
Innovation as Antidote
that can't afford any lost time. You know—the perfect kind of challenge for the HBS community. Last year, HBS and Harvard Medical School's Forum on Healthcare Innovation brought together everyone from biotech execs to policymakers in an... View Details
Keywords: Health, Social Assistance
- 01 Feb 2002
- News
Health Industry Alumni Convene for Conference
and CEO of Mediconsulting, Inc., spoke about creating a better model for business collaborations between biotech and pharmaceutical firms. Said Klietmann, the conference's biotechnology chair and a lecturer in pathology at Harvard Medical... View Details
- Profile
Arjun Goyal
at the back of my mind.” HBS stood out for two reasons. “It has a great network of alumni and professors in the biotech and pharmaceutical fields – both in world-leading corporations and startups,” says Arjun. “And HBS has a reputation... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
Above: illustration by Matthew Roharik/Getty Images In November 2019, a team from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, visited Moderna, Inc.’s manufacturing plant in Norwood, Massachusetts. The View Details
- Web
A Eureka Moment | Social Enterprise | Harvard Business School
further.” Bucala also launched a new venture focused on healthcare, serving as CEO at MIFCOR [www.mifcortx.com], a biotech company pursuing therapies for damaged heart tissue that recently received early stage funding. “I’m the sort of... View Details
- 01 Mar 2007
- News
Daniel Vasella
characterized by three things. First, we work closely with academic institutions and with biotech companies. Secondly, we created a genomics institute at The Scripps Research Institute in La Jolla, California. And the most important step... View Details
- 01 Jun 2001
- News
Christina Ehrenberg: The Examined Life
Goldman Sachs in asset management with a biotech focus. Of her HBS experience, Ehrenberg says, “Unlike the rote, top-down German education system, here you are an equal partner in ongoing learning and discussion. HBS has made me more... View Details
- Profile
Thomas Grenier
biotech investments. "I showed that it was far more profitable in the United States and that U.S. companies are better at developing new drugs." Thomas will continue to explore health care in his summer internship with... View Details
- 27 Sep 2019
- Blog Post
HBS Alumni and Students Take On the Climate Crisis
prairies west of Houston to mitigate the environmental impact of development through investment in conserving water-absorbing grasslands. THE BLUE-GREEN REVOLUTION Synthetic Genomics Inc., a private biotech company co-founded by Juan... View Details
- Web
IFC: Singapore; Shaping a Global Innovation Hub - Course Catalog
secured a strong lineup of speakers, each leaders in their respective fields, to offer students a broad range of perspectives as they engage with the coursework. Educational Objectives Through immersing students in Singapore’s burgeoning View Details
- 01 Jan 2006
- News
Philip L. Yeo, MBA 1976
R&D," explains Yeo. "A short time later, I set up the EDB's Singapore Bio Innovation Fund to invest longterm in overseas start-ups to learn as much as possible about the nascent biotech industry. And on June 26, 2000, the day the United... View Details
- 19 Sep 2012
- Research & Ideas
Funding Innovation: Is Your Firm Doing it Wrong?
its traditional slow-paced and bureaucratic system of R&D to emulate the relatively fast pace and entrepreneurial system of biotech companies." The firm created several specialized research teams to manage the innovation process.... View Details
Keywords: by Carmen Nobel
- Web
Class Profile | MBA
/ E-Commerce 9% Financial Services 10% Health Care / Biotech 8% Manufacturing / Industrial / Energy 9% Media / Entertainment / Travel 4% Military 5% Nonprofit / Government / Education 6% Services 2% Technology 12% Venture Capital /... View Details
- 01 Oct 2021
- News
Tackling the World’s Most Difficult Challenges
Sarnoff Professor of Business Administration, have long studied how artificial intelligence (AI) is changing the competitive landscape, but the example they explore in their “Moderna” case study is perhaps the most dramatic. The case takes students inside the View Details
- 01 Oct 1999
- News
Finance Conference Explores Research Methodologies
HBS assistant professor George Chacko, and HBS doctoral candidate Geoffrey Verter that looked at how risk management theory could be applied to understand a biotech firm's decision to buy call options on its own stock. In the final... View Details